Print version of this report

Type of Product	Medical Device
TGA Recall Reference	RC-2014-RN-00441-1
Product Name/Description	ADVIA Centaur, ADVIA Centaur XP and ADVIA Centaur CP ADVIA Centaur Systems TSH3 Ultra 100T, 500T Catalogue No: 06491072 & 06491080 Kit Lots Ending In: 266, 267, 269, 270, 271, 272 & 273 ADVIA Centaur Systems VitD 100T, 500T Catalogue No: 10491994, 10699201, 10631021 & 10699533 Kit Lots Ending In: 023, 024, 025, 026, 027, 050, 051, 052, 053 & 054 ADVIA Centaur BRAHMS PCT 100T Catalogue No: 10378883 Kit Lots Ending In: 020, 021, 022, 023 & 024 ARTG No: 175698 & 175700
Recall Action Level	Hospital
Recall Action Classification	Class II
Recall Action Commencement Date	17/04/2014
Responsible Entity	Siemens Ltd Diagnostics Division
Reason/Issue	Siemens Healthcare has confirmed that samples containing fluorescein (dye commonly used in fluroescein angiography) may show interference with the ADVIA Centaur Systems TSH3 Ultra, Vitamin D and the ADVIA Centaur BRAHMS Procalcitonin assays.
Recall Action	Recall for Product Correction
Recall Action Instructions	Siemens is notifying their customers of the potential for samples with fluorescein to show interference and the Instructions for Use are currently being updated.
Contact Information	1800 310 300 - Siemens Technical Support Centre